Effect of Celecxib in order to prevent spontaneous preterm labor
Phase 2
- Conditions
- Preterm Labor.Preterm spontaneous labour with preterm delivery
- Registration Number
- IRCT2015042621947N1
- Lead Sponsor
- Vice-Chancellor for Research of Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 164
Inclusion Criteria
Singleton pregnancy; Intact amniotic membrane; Gestational age between 24-34 weeks; Positive tocometry. Exclusion criteria: PROM; Vaginal bleeding; Chorioamnionitis; Dilatation more than 2 cm and cervical effacement exceeding 80%; Polyhydramnios; Oligohydramnios; Intrauterine Fetal Demise; Intrauterine Growth Restriction; Fetal distress; Smoking and alcohol abuse; systemic disease; Congenital anomalies; uterine anomalies; Celecxib intolerance.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preterm Labor. Timepoint: One hour after the onset of drug use until 24 hours. Method of measurement: Tocometer.
- Secondary Outcome Measures
Name Time Method